WELL Health Technologies Achieves Record Q2-2025 Results and Milestone Patient Visits

An update from WELL Health Technologies Corp ( (TSE:WELL) ) is now available.

WELL Health Technologies Corp reported record financial results for Q2-2025, achieving a 57% increase in quarterly revenues to $356.7 million, driven by organic growth and acquisitions. The company also marked its first-ever quarter with over 1 million patient visits in Canada, reflecting a 38% year-over-year growth. WELL’s strategic investments in Canadian clinics and technology have led to improved provider productivity and significant milestones in financial metrics, including Adjusted EBITDA and net income. The inclusion of HEALWELL AI contributed $40.5 million to revenue, and the company is considering strategic alternatives for its U.S. assets to focus on core Canadian operations.

The most recent analyst rating on (TSE:WELL) stock is a Buy with a C$6.00 price target. To see the full list of analyst forecasts on WELL Health Technologies Corp stock, see the TSE:WELL Stock Forecast page.

Spark’s Take on TSE:WELL Stock

According to Spark, TipRanks’ AI Analyst, TSE:WELL is a Neutral.

WELL Health Technologies Corp’s stock is driven by strong corporate events and revenue growth potential. However, financial performance issues, technical analysis signals, and valuation concerns weigh down the overall score. The company’s strategic initiatives and acquisitions could mitigate risks if executed successfully.

To see Spark’s full report on TSE:WELL stock, click here.

More about WELL Health Technologies Corp

WELL Health Technologies Corp is a digital healthcare company focused on enhancing health outcomes by leveraging technology to empower healthcare practitioners and patients globally.

Average Trading Volume: 844,965

Technical Sentiment Signal: Buy

Current Market Cap: C$1.22B

Learn more about WELL stock on TipRanks’ Stock Analysis page.